Sponsor

Duke-NUS Graduate Medical School

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Duke-NUS Graduate Medical School appears in 51 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials51
Recruiting shown6
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

51 shown
Trial of Artificial Intelligence for Chest RadiographyNCT06456203 · lead sponsor · 2024-10-01
UNKNOWN
Development and Evaluation of 'My Voice': A Randomized Controlled TrialNCT06090734 · lead sponsor · 2024-03-07
ACTIVE_NOT_RECRUITING
Understanding Grocery Shopping BehaviourNCT05018026 · lead sponsor · 2021-09-01
COMPLETED
A Randomized Trial to Slow the Progression of DiabetesNCT03800680 · lead sponsor · 2019-10-19
COMPLETED
Testing the Effects of Singapore's Front-of-Pack Healthier Choice Symbol Label With or Without a Physical Activity Equivalent LabelNCT04172337 · lead sponsor · 2019-01-01
COMPLETED
Marital Satisfaction and Sexual Health of Female Cancer Patients in SingaporeNCT03420547 · lead sponsor · 2018-11-01
COMPLETED
WIreless Monitoring and Financial Incentives for Uncontrolled HYpertension (WIFHY) StudyNCT03368417 · lead sponsor · 2017-12-20
TERMINATED
Evaluating the Effectiveness of Within Versus Across-Category Front-of-Package Lower-Calorie Labelling on Food DemandNCT04165447 · lead sponsor · 2017-10-01
COMPLETED
Singapore Cohort of Patients with Advanced Heart FailureNCT03089034 · lead sponsor · 2017-07-24
ACTIVE_NOT_RECRUITING
A Single Arm Feasibility Study of GlycoLeap, an On-line Lifestyle Modification and Self-management Program for People With Type 2 DiabetesNCT03091517 · lead sponsor · 2017-06-22
COMPLETED
Smartphone App Assisted Home Blood Pressure Monitoring Amongst Hypertensive Patients in SingaporeNCT03209024 · lead sponsor · 2017-03-15
UNKNOWN
Management of Hypertension and Multiple Risk Factors to Enhance Cardiovascular HealthNCT02972619 · lead sponsor · 2017-01-15
UNKNOWN
Behavioral Symptom Management Program for Breast Cancer in Singapore and The USNCT02865148 · lead sponsor · 2016-08-01
COMPLETED
Primary Care Strategies to Reduce High Blood Pressure: A Cluster Randomized Trial in Rural Bangladesh, Pakistan and Sri LankaNCT02657746 · lead sponsor · 2016-05-01
UNKNOWN
Brain-Computer Interface System for Training Memory and Attention in ElderlyNCT02228187 · lead sponsor · 2015-07-01
COMPLETED
Trial to Incentivise Adherence for DiabetesNCT02224417 · lead sponsor · 2015-03-01
COMPLETED
Impact of Advance Care Planning on Care for Patients With Advanced Heart FailureNCT02299180 · lead sponsor · 2015-02-01
COMPLETED
Study on Incentives for Glaucoma Medications AdherenceNCT02271269 · lead sponsor · 2014-11-01
COMPLETED
Control of Blood Pressure and Risk Attenuation-rural Bangladesh, Pakistan, Sri Lanka, Feasibility StudyNCT02341651 · lead sponsor · 2014-08-01
COMPLETED
Management of Hypertension and Multiple Risk Factors to Enhance Cardiovascular HealthNCT02330224 · lead sponsor · 2014-07-01
COMPLETED
Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD)NCT03281083 · lead sponsor · 2014-03-28
TERMINATED
A Randomized Incentive-Based Weight Loss Trial in SingaporeNCT01533454 · lead sponsor · 2012-09-01
COMPLETED
Effectiveness of a Brain-Computer Interface Based System for Cognitive Enhancement in the Normal ElderlyNCT01661894 · lead sponsor · 2012-04-01
COMPLETED
The Singapore Chinese Health StudyNCT03356340 · lead sponsor · 1993-04-01
UNKNOWN
Potential of Interface Care Models to Deliver More Appropriate Care to Patients With Acute Medical IllnessNCT07536035 · collaborator · 2024-09-30
RECRUITING
Pilot Study of the Human Metagenome in Metabolic DiseasesNCT06363253 · collaborator · 2023-08-14
RECRUITING
SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE)NCT05724264 · collaborator · 2022-07-21
RECRUITING
The Glaucoma Nicotinamide TrialNCT05275738 · collaborator · 2022-05-18
RECRUITING
Integrating Community LITE Programme as an Online Family-based Intervention to Combat Childhood ObesityNCT05281016 · collaborator · 2022-04-22
RECRUITING
Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer PatientsNCT04340024 · collaborator · 2015-09-30
RECRUITING
EMPOWERing Patients With Chronic Diseases Through Smartphone App, Health Coaching and Shared Decision MakingNCT05486390 · collaborator · 2023-02-17
UNKNOWN
Impact of Bilingual Prescription Medication Labels Among Elderly SingaporeansNCT05101330 · collaborator · 2021-11-01
WITHDRAWN
Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS)NCT05081037 · collaborator · 2021-09-06
ACTIVE_NOT_RECRUITING
Empowering Patients With Chronic Disease Using Profiling and Targeted Feedbacks Delivered Through Wearable DeviceNCT04518566 · collaborator · 2021-05-11
COMPLETED
Brown Fat Activation and Browning Efficiency Augmented by Chronic Cold and Nutraceuticals for Brown Adipose Tissue-mediated Effect Against Metabolic Syndrome (BEACON BEAMS Study)NCT04595006 · collaborator · 2021-01-15
ACTIVE_NOT_RECRUITING
A Novel School-clinic-community Online Model of Child Obesity Treatment in Singapore During COVID-19NCT04395430 · collaborator · 2020-09-18
COMPLETED
Metabolic Effects of the SGLT-2 Inhibitor Empagliflozin in Patients With Diabetic Nephropathy (MEDiaN)NCT03933956 · collaborator · 2020-01-09
TERMINATED
Hepato-renal Regulation of Water Conservation in Heart Failure Patients With SGLT-2 Inhibitor TreatmentNCT04080518 · collaborator · 2019-11-11
COMPLETED
The Association of Maternal Night-Eating Pattern With Glucose Tolerance During PregnancyNCT03803345 · collaborator · 2019-03-28
COMPLETED
Time Restricted Eating As Treatment (TREAT) for Diabetes Mellitus: A Pre-Post 12 Week Study on the Effectiveness of Intermittent Fasting in Asians With Type 2 Diabetes MellitusNCT03940482 · collaborator · 2019-01-14
UNKNOWN
Obesity-Related Glycine Deficiency: Investigating a Long-standing Metabolic Paradox Using Bedside and Bench ApproachesNCT04660513 · collaborator · 2018-12-08
COMPLETED
Mobile Health Intervention to Identify Early Responders to Treatment in Adolescent ObesityNCT03561597 · collaborator · 2018-04-10
COMPLETED
The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) ProgramNCT03503942 · collaborator · 2017-12-30
COMPLETED
Remote Ischaemic Conditioning on Blood Pressure Control in Chronic Kidney Disease PatientsNCT03236350 · collaborator · 2017-11-28
UNKNOWN
Enhancing Quality of Life in Patients (EQUIP) Intervention for Patients With Advanced Lung CancerNCT02801734 · collaborator · 2016-08-01
COMPLETED
Insulin Resistance and Mild Cognitive Impairment (IRMCI) StudyNCT02409238 · collaborator · 2015-03-11
TERMINATED
Identification and Metabolic Characterization of a Cohort of Human Subjects With Mutations in PRDM-16NCT02808715 · collaborator · 2014-05-01
COMPLETED
Novel Retinal Imaging Biomarkers in Early Alzheimer's DiseaseNCT01937221 · collaborator · 2013-09-01
COMPLETED
Feasibility of Using a Smart Phone Application for Self-titration of Insulin on Glycemic Control in Patients With T2DMNCT01950676 · collaborator · 2013-03-01
COMPLETED
Vitamin D Supplementation in Patients With Diabetes Mellitus Type 2NCT01741181 · collaborator · 2012-09-01
COMPLETED
The Effect of 90-day Oral Testosterone Therapy in Chinese Males With Type 2 Diabetes (T2DM)NCT01510847 · collaborator · 2011-10-01
TERMINATED

Drugs studied in this sponsor's trials

3 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Duke-NUS Graduate Medical School as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
metformin2
empagliflozin 10 MG1
levothyroxine sodium1
metformin RxCUI 6809 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials empagliflozin 10 MG RxCUI 1545654 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial levothyroxine sodium RxCUI 40144 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

collaborator27
lead sponsor24
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.